ATE481414T1 - Von kollagen typ iv abgeleitetes cyclopeptid mit antikrebswirkung - Google Patents

Von kollagen typ iv abgeleitetes cyclopeptid mit antikrebswirkung

Info

Publication number
ATE481414T1
ATE481414T1 AT07731176T AT07731176T ATE481414T1 AT E481414 T1 ATE481414 T1 AT E481414T1 AT 07731176 T AT07731176 T AT 07731176T AT 07731176 T AT07731176 T AT 07731176T AT E481414 T1 ATE481414 T1 AT E481414T1
Authority
AT
Austria
Prior art keywords
cyclopeptide
derived
collagen type
cancer effect
ysns
Prior art date
Application number
AT07731176T
Other languages
English (en)
Inventor
Jean-Claude Monboisse
Laurent Ramont
Sylvie Brassart
Nicolas Floquet
Jessica Thevenard
Original Assignee
Univ Reims Champagne Ardenne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Reims Champagne Ardenne filed Critical Univ Reims Champagne Ardenne
Application granted granted Critical
Publication of ATE481414T1 publication Critical patent/ATE481414T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126—Tetrapeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT07731176T 2006-03-23 2007-03-22 Von kollagen typ iv abgeleitetes cyclopeptid mit antikrebswirkung ATE481414T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0602530A FR2898895B1 (fr) 2006-03-23 2006-03-23 Cyclopeptide a activite anti-cancereuse derive du collagene de type iv
PCT/FR2007/000487 WO2007107654A1 (fr) 2006-03-23 2007-03-22 Cyclopeptide a activite anti-cancereuse derive du collagene de type iv

Publications (1)

Publication Number Publication Date
ATE481414T1 true ATE481414T1 (de) 2010-10-15

Family

ID=37027542

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07731176T ATE481414T1 (de) 2006-03-23 2007-03-22 Von kollagen typ iv abgeleitetes cyclopeptid mit antikrebswirkung

Country Status (7)

Country Link
US (1) US20090305955A1 (de)
EP (1) EP1996608B1 (de)
AT (1) ATE481414T1 (de)
DE (1) DE602007009204D1 (de)
ES (1) ES2360004T3 (de)
FR (1) FR2898895B1 (de)
WO (1) WO2007107654A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2490655A (en) * 2011-04-28 2012-11-14 Univ Aston Modulators of tissue transglutaminase
JP6076509B2 (ja) * 2014-02-07 2017-02-08 ミヤリサン製薬株式会社 クロストリジウム属の菌の毒素産生抑制活性を有するペプチド
CN103897038A (zh) * 2014-04-11 2014-07-02 中国药科大学 一种肿瘤抑制多肽及用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010052566A (ko) * 1998-06-03 2001-06-25 윌리엄 뉴 엔도스타틴 단백질을 포함하는 단백질 올리고머 조성물 및이의 사용방법
US20030166003A1 (en) * 1999-06-14 2003-09-04 Cochran Andrea G. Structured peptide scaffold for displaying turn libraries on phage
CN1420926A (zh) * 2000-01-07 2003-05-28 贝丝以色列迪克尼斯医疗中心 抗生血管蛋白和片段及其应用方法
AU2001264716A1 (en) * 2000-05-18 2001-11-26 Oregon Health And Science University Cloning of rhadinovirus genome and methods for its use
CA2432932A1 (en) * 2001-02-16 2002-08-29 Mark A. Scialdone Angiogenesis-inhibitory tripeptides, compositions and their methods of use
US7714109B2 (en) * 2002-07-15 2010-05-11 Board Of Regents, The University Of Texas System Combinations and kits for cancer treatment using selected antibodies to aminophospholipids

Also Published As

Publication number Publication date
WO2007107654A1 (fr) 2007-09-27
EP1996608B1 (de) 2010-09-15
WO2007107654A8 (fr) 2009-07-16
US20090305955A1 (en) 2009-12-10
FR2898895A1 (fr) 2007-09-28
DE602007009204D1 (de) 2010-10-28
ES2360004T3 (es) 2011-05-31
FR2898895B1 (fr) 2012-04-06
EP1996608A1 (de) 2008-12-03

Similar Documents

Publication Publication Date Title
BR112016004095A2 (pt) administração de enzimas de empobrecimento de quinurenina para a terapia contra tumores
BR112015016681A8 (pt) uso de nanopartículas compreendendo paclitaxel e uma albumina, kit, medicamento, composição e forma de dosagem unitária para tratamento de câncer pancreático
PL385586A1 (pl) Nowe analogi insuliny o przedłużonym działaniu
BR112015022507A2 (pt) ácidos ribonucleicos com nucleotídeos 4'-tio-modificados, composição compreendendo o mesmo e usos relacionados
MY156243A (en) Treatment for diabetes in patients inappropriate for metformin therapy
TN2011000200A1 (en) Combination therapy with peptide epoxyketones
BR112012029975A2 (pt) peptídeo como medicamento, em particular para o tratamento do câncer.
UA117096C2 (uk) Поліпептид, що зв'язується з c5 комплементу людини
UA107783C2 (en) Isoindoline compounds for use in treating cancer
WO2009149339A3 (en) P53 activator peptides
CY1110980T1 (el) Εμβολιο συνδυασμων πεπτιδιων εναντια στην αλλεργια απο γατες
BR112015019064A2 (pt) métodos de tratamento de melanoma
MX2009007068A (es) Composiciones y metodos de aplicacion topica y suministro transdermico de toxinas botulinicas estabilizadas con fragmentos de polipeptido provenientes de hiv-tat.
PH12015500186A1 (en) Combination therapies for melanoma comprising administering cobimetinib and vemurafinib
EA201390506A1 (ru) Полипептиды, которые связывают компонент с5 комплемента человека
CR20120508A (es) PROTEÍNA DE FUSIÓN ROBO1-Fc Y SU UTILIZACIÓN EN EL TRATAMIENTO DE TUMORES
EP3747457A3 (de) Faktor-1-protein, faktor-2-protein und inhibitoren davon zur verwendung bei der behandlung und prävention von erkrankungen
NZ607892A (en) Tfpi inhibitors and methods of use
ATE510907T1 (de) Adenovirus mit mutationen in der domäne des e3- 19k-proteins zur retention im endoplasmatischen retikulum und verwendung in der krebsbehandlung
WO2014140103A3 (en) Thrombin sensitive coagulation factor x molecules
SG191060A1 (en) Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
EA201200428A1 (ru) Композиция и способ для лечения ожирения
ATE538799T1 (de) Zusammensetzungen zur behandlung von haarverlust
MX2010008994A (es) Combinacion que comprende paclitaxel para el tratamiento del cancer de ovario.
ATE481414T1 (de) Von kollagen typ iv abgeleitetes cyclopeptid mit antikrebswirkung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties